Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004138
Filing Date
2021-11-10
Accepted
2021-11-10 16:43:25
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20210930.htm   iXBRL 10-Q 2677288
2 EX-31.1 glue-ex31_1.htm EX-31.1 18989
3 EX-31.2 glue-ex31_2.htm EX-31.2 18983
4 EX-32.1 glue-ex32_1.htm EX-32.1 10656
5 EX-32.2 glue-ex32_2.htm EX-32.2 10652
  Complete submission text file 0000950170-21-004138.txt   7107970

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glue-20210930_pre.xml EX-101.PRE 258843
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glue-20210930_lab.xml EX-101.LAB 331595
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glue-20210930_def.xml EX-101.DEF 132012
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glue-20210930_cal.xml EX-101.CAL 25726
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glue-20210930.xsd EX-101.SCH 36481
11 EXTRACTED XBRL INSTANCE DOCUMENT glue-20210930_htm.xml XML 1010120
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40522 | Film No.: 211397402
SIC: 2836 Biological Products, (No Diagnostic Substances)